There is a paradox at the heart of UK medical workforce policy that every MLA candidate should understand, because it will define the profession they are about to enter. The United Kingdom is simultaneously training more medical students than at any point in its history and presiding over a system in which newly qualified doctors face an increasingly uncertain pathway into specialty training, clinical employment, and long-term career progression. The 2023 NHS Long Term Workforce Plan pledged to double medical school places to 15,000 by 2031-32. But postgraduate training posts have not expanded in anything close to proportion. The result, by 2025 and into 2026, is an unprecedented bottleneck - a training crisis that has provoked emergency legislation, professional anger, and a fundamental rethinking of who gets to become a doctor in the UK.
For candidates preparing for the AKT and MLA, this is not abstract health policy. It touches directly on clinical governance, workforce planning, professional regulation, ethical resource allocation, and the sustainability of medical education itself - all domains that the licensing assessment expects newly qualified doctors to understand.
The Numbers: An Expansion Without a Plan
The NHS Long Term Workforce Plan, published in June 2023, represented the first comprehensive attempt to plan strategically for the future NHS workforce in England. Its headline commitment - doubling medical school places from approximately 7,500 to 15,000 - was broadly welcomed by a profession that had long argued the UK was under-doctored. OECD data consistently placed the UK near the bottom of European league tables for doctors per capita, and the post-pandemic backlog made the case for workforce expansion seem unanswerable.
Yet even at the time, critics raised uncomfortable questions about implementation. A scoping review published in Medical Education in 2025 by Sassoon and Craig identified funding as the most frequently raised concern in the literature, followed by educator shortage, limited stakeholder engagement, placement capacity constraints, and a failure to support widening access agendas. Additional 350 places were allocated for the 2025-26 intake, bringing the total increment to 555 new places over two years. But by February 2026, The BMJ was reporting that student admissions for 2025-26 and 2026-27 fell well below the trajectory required to reach 15,000 by 2031-32 - and that the government was quietly retreating from Rishi Sunak's original target. Novel training routes, including the medical doctor degree apprenticeship, were paused before they had begun, and the four-year accelerated undergraduate medical degree, expected to commence in 2026, had produced little published progress.
More troubling than the shortfall against the expansion target, however, was what was happening at the other end of the pipeline.
The Training Bottleneck: Competition Without Precedent
While medical school places grew modestly, postgraduate specialty training posts remained largely static. NHS England data shows that the number of CT1/ST1 training posts rose only marginally - from 9,235 in 2022 to 9,479 in 2025. Over the same period, the number of applications surged. In 2019, approximately 12,000 applicants competed for around 9,000 specialty training places - a competition ratio of 1.4 to 1. By 2025, there were 80,218 applications for 9,479 posts, yielding a headline ratio of 8.4 applications per place. Even adjusting for multiple applications per candidate (an average of 2.37 in 2025), the unique applicant-to-post ratio stood at 3.57 to 1, meaning 72 per cent of applicants - approximately 24,000 doctors - were rejected.
The drivers of this escalation are multiple and contested. The lifting of visa restrictions in 2020, when medicine was added to the shortage occupation list and the Resident Labour Market Test was abolished, dramatically increased the number of international medical graduates (IMGs) applying for UK training posts. Government impact assessment data published in January 2026 revealed that in 2025, 15,723 UK-trained doctors and 25,257 overseas-trained doctors competed for 12,833 round 1 and 2 posts. For the 2026 cycle, over 47,000 applications were received. The UKFPO careers destination survey found that only 68.4 per cent of Foundation Year 2 respondents had confirmed medical employment post-FY2, down from 80.8 per cent the previous year. As the BMA medical students committee chair Rob Tucker put it, the system was expanding medical school places while failing to create the jobs those graduates would need.
Who Will Teach the Next Generation? The Clinical Academic Crisis
The expansion of student numbers has collided with an equally serious problem on the supply side of medical education. Clinical academics - doctors who combine patient care, teaching, and research - form the backbone of medical school delivery. Yet Medical Schools Council data, published in successive annual surveys, document a workforce in sustained decline. By 2025, 36 per cent of clinical academics were aged over 55, and among professors the figure was 65 per cent. Reader and senior lecturer grades experienced a 25 per cent decline between 2011 and 2021, even as medical student numbers climbed. Significant gender and ethnic imbalances persist, with ethnic minority academics constituting only one fifth of the full-time equivalent workforce and Black/Black British clinical academics representing less than one per cent.
Ferreira and Collins, writing in Human Resources for Health in December 2025, argued explicitly for an immediate moratorium on medical school expansion until the clinical academic workforce could be stabilised. They warned that the mismatch between workforce enlargement and existing infrastructure, combined with an educator base that was both ageing and shrinking, raised fundamental questions about the feasibility of maintaining educational standards. New medical schools, some with limited track records, were being established at a time when the pool of experienced educators available to staff them was contracting. The BMA reported in March 2026 that medical students in some institutions had as little as two days of clinical placement across an entire four-week block - a quality of educational experience that the BMA's medical students committee described as inadequate.
Montgomery, writing for the Faculty of Pharmaceutical Medicine in September 2025, situated this within a broader narrative of decline, linking the training bottleneck to the erosion of clinical academic careers. Doctors who previously would have taken research posts between foundation training and specialty applications - strengthening their CVs, gaining academic experience, and sometimes discovering a vocation in clinical research - now found those routes foreclosed by the urgency of securing any available training number. The pipeline that had historically replenished the clinical academic workforce was, in effect, being cut off by the very bottleneck it was supposed to mitigate.
The Medical Training (Prioritisation) Act 2026: Emergency Legislation
The political response to the training bottleneck came in the form of emergency legislation. The Medical Training (Prioritisation) Bill was introduced to the House of Commons on 13 January 2026 and fast-tracked through all parliamentary stages, receiving Royal Assent on 5 March 2026. The Act establishes a system of prioritisation for both foundation and specialty training, giving precedence to UK medical graduates, graduates of Republic of Ireland medical schools (reflecting the special bilateral relationship), and graduates from Iceland, Liechtenstein, Norway, and Switzerland under existing international agreements. For 2026, specialty training prioritisation applies at the offer stage; from 2027, it will apply at both shortlisting and offer.
The government accompanied the Act with a commitment to create 1,000 additional specialty training posts in England, with applications opening from April 2026. While the BMA acknowledged this as a positive step, it emphasised that 1,000 posts would not close the gap when tens of thousands of doctors were competing for roughly 13,000 places. The legislation also provoked significant ethical and practical controversy.
The Ethical Dimension: Who Deserves a Training Post?
The prioritisation of UK graduates raises difficult questions about fairness, global health equity, and the NHS's historical dependence on international recruitment. International medical graduates are not merely filling gaps created by domestic under-training; they are, in many specialties and many regions, the clinical workforce without which services would collapse. General practice is particularly reliant on IMGs. The GMC's 2024 workforce report showed that record growth in the UK's licensed doctor population - up 23 per cent in a single year - was driven almost entirely by international joiners, many taking locally employed doctor (LED) positions outside the national training programme.
During House of Lords debate on the Bill, members raised concerns about changing the rules for applicants who were already mid-cycle - some of whom had relocated internationally, obtained visas, and paid substantial examination fees. The British Association of Physicians of Indian Origin (BAPIO), in a March 2026 editorial, cautioned against narratives that characterised IMGs as inherently less competent, noting that higher GMC referral rates for overseas-trained doctors may reflect case mix, workplace bias, and the concentration of IMGs in high-pressure posts rather than genuine competence differences. The Nuffield Trust separately flagged the NHS's continued overreliance on doctors recruited from WHO 'red list' countries - nations with their own critical workforce shortages - raising questions about the global ethics of the UK's recruitment patterns.
Defenders of the legislation argued that the taxpayer invests £4.3 billion annually in training medical graduates, and that a system where UK-trained doctors could complete six or more years of medical school only to face unemployment or indefinite career limbo was both wasteful and demoralising. The BMA resident doctors committee, while noting the Act did not go far enough, described it as an important step toward ending a jobs crisis that had pushed many young doctors toward emigration - a brain drain that The Telegraph reported was seeing thousands of doctors leave Britain, further undermining the workforce the expansion was supposed to strengthen.
Quality Under Pressure: Can Standards Survive?
The GMC's quality assurance framework for new medical schools involves self-assessment, screening visits, annual follow-ups, and sign-off by Council. But Ferreira and Collins warned that each stage is vulnerable to resource limitations, particularly when the educator base is shrinking. Assessment practices already vary markedly between existing medical schools in volume, style, and difficulty, raising questions about whether the MLA itself can provide the standardising function that a rapidly diversifying medical school landscape requires. The establishment of new schools under financial pressure - at a time when UK higher education faces a broader funding crisis, with sector debts exceeding £10.8 billion - risks institutions prioritising student numbers over educational quality in order to remain financially viable.
Scotland presents a particularly sharp case study: medical student numbers have expanded to almost twice the per-capita rate of England, but largely within existing institutions rather than through new schools. The BMA reported in March 2026 that this had led to overcrowded clinical placements, large groups of students at ward rounds making patients uncomfortable, and limited learning opportunities. The quality of graduates, the BMA cautioned, was being maintained in spite of the circumstances they trained in, not because of them - and that this was unlikely to remain sustainable.
Relevance to the AKT and MLA
This controversy sits squarely within the MLA's examinable domains. Questions on NHS structure and healthcare delivery may test understanding of workforce planning, the distinction between foundation and specialty training, and the role of bodies such as NHS England and the GMC in regulating the training pipeline. The ethical tensions around resource allocation - who should be prioritised for scarce training posts, and on what basis - are directly relevant to medical ethics and law, with the Prioritisation Act offering a contemporary case study in the competing principles of fairness, efficiency, and global equity.
Candidates should understand the concept of competition ratios and their drivers, the role of the Medical Training (Prioritisation) Act 2026 in reshaping training access, and the broader tension between medical school expansion and postgraduate training capacity. The clinical academic workforce decline connects to questions about clinical education quality, research governance, and the evidence base for clinical practice. And the debate about international graduates touches on professionalism, the NHS Constitution, and the principle that the health service should treat its workforce - wherever trained - with dignity and respect. Taken together, these issues offer a vivid illustration of how workforce policy, education quality, and patient safety are inextricably linked - a lesson that the MLA expects every newly licensed doctor to have grasped.